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Abstract: Seaweeds contains different types of polysaccharides with high abilities. The aim of this study was to determine the potential
of fucoidan polysaccharides for wound-healing properties. Fucoidans of two species of Padina (P. tetrastromatica and P. boergesenii),
collected from the Persian Gulf northern coastal area, were extracted and analyzed using high-performance anion-exchange
chromatography. Purified fucoidans were used to prepare a 2% topical ointment. Under aseptic conditions, two identical paravertebral
full-thickness skin wounds (either by burn or excision) were made in 40 anesthetized male rats allocated into 4 groups. Either fucoidan
ointments or the vehicle (ointment base) were applied to rats’ wounds twice daily for 14 days. In addition to the examination of wound
area reduction (days 3, 7, 10, and 14) and histopathological assays (days 7 and 10), tissue specimens were taken to the laboratory.
Fucoidans obtained from both seaweeds induced significant wound area reduction compared to the vehicle at some time points after
treatment. Histopathological examinations showed improvement in some healing signs including angiogenesis, collagen fiber formation,
and epidermis formation. In conclusion, both species of Padina have significant wound-healing effects and fucoidan polysaccharides are
the active constituents for this healing property. However, fucoidan obtained from P. boergesenii showed superior effects in this regard.
Key words: Fucoidan polysaccharides, burn wound, excisional wound, wound healing, rat

1. Introduction
Brown algae or Phaeophyceae are widely distributed
tropical marine seaweeds whose chemical constituents
include fucoidans, alginates, and some other types of
polysaccharides with interesting biological activities
(1,2). Fucoidans are sulfated polysaccharides (composed
of fucose, glucose, xylose, galactose, etc.) existing in the
brown seaweeds (3). They have molecular structures
similar to heparin and were recently introduced as
candidates for wound healing (4). Other properties of
these important seaweed constituents include antioxidant,
antithrombotic, antiinflammatory, antitumoral, and
antiviral effects (5,6). Fucoidans obtained from different
species and geographical areas have different structures
with potential diversity in their pharmacological activities
(7,8). However, there is little information on their in vivo
wound-healing effects to date.
* Correspondence: kordjazi.m@gmail.com

106

Wound healing, as a complex process, has been
extensively subjected to numerous medical and
pharmacological studies in the recent decades. The three
main phases in wound healing, after primary cessation
of bleeding (hemostasis) and clotting, are inflammation,
proliferation, and maturation (9). To improve the woundhealing process by a substance, at least one of these phases
must be enhanced. Skin burns and cut wounds are two
common traumas that sometimes need extensive care in
daily human life. The complexity of the wound-healing
process in addition to the shortage of effective medicines
has initiated numerous investigations of new drug
candidates.
Marine products, and especially algae derivatives, have
shown many interesting activities and their constituents
have been investigated in medical studies since ancient
times. Seaweeds have long been recognized as rich
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and valuable natural remedies because of their various
biological properties (10,11). In the present study, the
fucoidan content of two main species of Padina (P.
tetrastromatica and P. boergesenii) collected from the
northern coasts of the Persian Gulf was extracted and
purified as it might have distinct pharmacological effects
to be of benefit in wound-healing processes. This study
was designed to evaluate the histopathological changes in
rat burn and excisional skin wound models after topical
administration of purified fucoidans.
2. Materials and methods
2.1. Raw material
P. tetrastromatica and P. boergesenii were collected from
the Kani (26°34′344″N, 55°23′765″E) and Bahman
(26°57′645″N, 56°16′646″E) ports of Qeshm Island, Iran.
Taxonomic identification of the specimens was done at the
Persian Gulf Biotechnology Park (P. tetrastromatica No.
66-20 p and P. boergesenii No. 44-14 p). After drying at
room temperature, the raw algal mass was powdered by
a mechanical blender and later sieved to obtain uniform
powdered samples. Fresh samples were kept frozen at –20
°C for further analysis.
2.2. Extraction of fucoidan polysaccharides
Fucoidan polysaccharides were extracted from powdered
algal masses according to the procedure of Yang et al. (12).
Briefly, the dried samples (20 g) were extracted twice with
distilled water (400 mL) at 65 °C while stirring for 2 h.
The obtained extracts were combined and centrifuged at
13,000 × g for 10 min. The supernatant was mixed with 1%
CaCl2 and kept at 4 °C overnight to precipitate alginic acid.
The solution was centrifuged at 13,000 × g for 10 min and
EtOH (96%) was added to the supernatant to reach a final
concentration of 30%. The latter solution was kept at room
temperature for 4 h, and then centrifuged at 13,000 × g
for 15 min. The alcohol concentration in the supernatant
was increased to 70% and it was kept at 4 °C overnight.
Using a nylon membrane (0.45-µm pore size, Whatman
International Ltd., UK), and following washing with
EtOH (96%) and acetone, the brown-yellowish creamy
precipitates were collected and dried at room temperature
in a desiccator. The yield of fucoidan purification was
reported based on the weight of the primary dried samples.
2.3. Sample preparation for high-performance anionexchange chromatography with pulsed amperometric
detection (HPAEC-PAD)
Approximately 15–20 mg of purified fucoidans (particle
size: 200–500 µm) was dissolved in deionized water. Then,
after adding 600 µL of 2 M trifluoroacetic acid, the apparatus
was heated at 121 °C in a drying oven for 2 h without
stirring and allowed to cool off at room temperature.
Hydrolysates were lyophilized and kept at –20 °C until

analysis. Prior to analysis by HPAEC-PAD, the lyophilized
sample hydrolysates were dissolved in 5 mL of double
deionized water. The prepared total fucoidans were filtered
through 0.20-µm nylon syringe filters into the sample vials
used for the AS50 autosampling chromatography system.
2.3.1. Determination of carbohydrate composition
The HPAEC-PAD analysis of the fucoidan samples was
performed as previously described by Arnous and Meyer
(13). The monosaccharide contents of the hydrolysates and
standards were determined using a BioLC system consisting
of a GS50 gradient pump, an AS50 chromatograph, and
an ED50 electrochemical detector coupled to an AS50
autosampler (Dionex Corp., Sunnyvale, CA, USA). The
separation was performed using a CarboPacTM PA20
analytical column (3 × 150 mm) (Dionex Corp.) and the
eluent flow rate was 0.5 mL/min. The monosaccharides
were separated using a double eluent system consisting
of deionized water and NaOH (500 mM). Neutral
monosaccharides were eluted isocratically with 2.5 mM
NaOH for 20 min followed by a second isocratic elution
for 10 min by a higher NaOH concentration (500 mM)
to elute acidic monosaccharides (guluronic). This high
concentration of NaOH simultaneously was used to wash
the column. Before each injection (10 µL), a column
reequilibration program was run for 5 min with 100 mM
NaOH followed by another 5 min with 2.5 mM NaOH.
Different carbohydrate standards were mixed to resemble
the matrix of the fucoidans’ lysates. Data collection was
performed using the following pulse potentials/durations
for detections: E1 ¼ 0.1 V, t1 ¼ 400 ms; E2 ¼ 2 V, t2 ¼ 20
ms; E3 ¼ 0.6 V, t3 ¼ 10 ms; E4 ¼ 0.1 V, t4 ¼ 70 ms, data
collection rate: 0.2 Hz (13).
2.3.2. Determination of fucoidans’ sulfate content
One of the important characteristics of fucoidans is the
percentage of their sulfate contents, which was determined
by the following procedure. From 1.1 mL of the fucoidan
aqueous solution (0.05%), 1.2 mL of 8% trichloroacetic
acid was added and mixed well, and then 0.6 mL of the
appropriate agarose-BaCl2 reagent (0.02% and 0.5%) was
added and the mixture was allowed to stand for 35 min
(at which time turbidity reaches its maximum and remains
stable for over 1 h). After shaking the samples, the optical
density was read at 500 nm using a spectrophotometer
(14).
2.4. Fucoidan ointment preparation
After dissolving 750 mg of fucoidan powder in 4 mL of
distilled water, 2% ointments of each fucoidan sample were
prepared using Eucerin, which served as the ointment
vehicle for the preparation of the negative control as well.
2.5. Animals
The study was conducted in accordance with European
Community guidelines and was approved by the Animal
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Ethics Committee of Babol University of Medical Sciences
(BUMS). A total of 40 male Wistar rats (Rattus norvegicus)
were used, with body weights ranging from 200 to 250 g,
obtained from the Animal Center of BUMS. The animals’
general health conditions were examined at the beginning,
and they received food and water ad libitum. The animals
were housed individually in transparent polystyrene cages.
They were kept at conditioned room temperature (22 ± 2
°C) with a 12-h photoperiod.
2.5.1. Burn and excisional wound models
Experimental groups were divided randomly into 4
groups of 10. The first group was topically treated with
P. tetrastromatica (right: treatment, left: control) for burn
wounds, the second group was topically treated with
P. boergesenii (right: treatment, left: control) for burn
wounds, the third group was treated with P. tetrastromatica
(right: treatment, left: control) for excisional wounds, and
the fourth group was treated with P. boergesenii (right:
treatment, left: control) for excisional wounds. For fullthickness burn wounds, two equally sized bilateral wounds
were created on the backs of rats (n = 20) under anesthesia
with pentobarbital (50 mg/kg; i.p.). Briefly, using an
electric hair clipper, the rats’ back fur was removed and
the skin was wiped with warm distilled water (37 °C) and
consequently 70% ethanol for cleansing. Using boiling
water, a customized iron rod (with 10-mm cut diameter)
was heated to 96 °C and then applied to the shaved rats’
skin for 20 s to cause a second-degree burn wound (15).
To produce excisional wounds, a standard size (2 × 2 cm)
skin excision was made on rats’ backs (n = 20) on each side
(right = treatment and left = control) under anesthesia.
The fucoidan ointments or 250 mg of Eucerin alone (the
ointment base for the control wound) were applied to the
lesions twice a day for 2 weeks (5 days per week) (16).
2.6. Wound area reduction
All the rats were examined for wound area reduction
under anesthesia. The burn or excisional wound area
was measured manually using a transparent grid on days
3, 7, 10, and 14 (planimetry method). The wound area
reduction was expressed as reduction in percentage of
original wound size (17):

% wound reduction rate on day X= [(area on day 0, mm2
– open area on day X, mm2) / area on day 0, mm2] × 100.
2.7. Histopathological examination
From each group, five rats on day 7 and the rest of
the animals (5 rats) on day 14 were euthanized using
pentobarbital overdose and the skin of the whole wound
area was removed for histopathological examination.
The tissue samples (after fixing in formalin and
dehydrating by ethanol and xylol) were embedded in
paraffin, sectioned at 5 µm in thicknesses, deparaffinized,
and stained with hematoxylin and eosin. The stained tissue
glass mounted slides were examined using a light microscope
for histopathological alteration in wounds samples.
2.8. Statistical analysis
The results were expressed as mean ± standard deviation
(SD). All statistical analysis was performed using SPSS
18 (SPSS Inc., Chicago, IL, USA). Student’s paired and
independent t-test was used to test the significance of
differences between means. P < 0.05 was interpreted as a
significant difference between means.
3. Results
3.1. Fucoidan extraction and compositional analysis
The yields of fucoidan extraction for P. tetrastromatica and
P. boergesenii were calculated to be 1 ± 0.5% and 4.5 ± 0.5%,
respectively. Fucoidan compositions were mainly made up
of fucose and galactose with significant levels of sulfate.
As shown in the Table, other monosaccharides (mainly
rhamnose) were minor in both fucoidan samples. The
two fucoidan samples showed similar sulfation levels and
monosaccharide types; however, the fucose and glucose
content of P. tetrastromatica was significantly higher than
that of P. boergesenii (Table).
3.2. Effects on wound area reduction
Effects of treatment are shown in Figures 1–6. As shown
in Figures 1 and 2, the P. boergesenii topical ointment had
significant effects (P < 0.05) on wound area reduction
for both burn and excisional wounds. This effect was
observable in excisional wounds from day 3 and reached
its maximum at day 7 (Figure 2). On the other hand, P.

Table. Monosaccharides and sulfate compositions (mean ± SD) (%) of fucoidans derived from P. tetrastromatica and P. boergesenii.

Samples

Monosaccharides/sulfate compositions (%) (DW)
Fuc

Rha

Gal

Glc

Xyl

Man

Glu acid

Sulfate

P. tetrastromatica

29.65 ± 3.33

1.09 ± 0.16

17.28 ± 1.01

11.35 ± 0.35

5.63 ± 0.24

4.54 ± 0.36

8.89 ± 0.1

19 ± 1

P. boergesenii

10.72 ± 1.29

3.90 ± 0.58

18.23 ± 2.22

4.87 ± 0.51

5.26 ± 0.87

3.99 ± 0.44

7.22 ± 0.89

32.6 ± 1

*Monosaccharide compositions: Fuc = fucose, Rha = rhamnose, Gal = galactose, Glc = glucose, Xyl = xylose, Man = mannose, Glu acid = glucuronic
acid, DW = dried weight.
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Figure 1. Burn wound area reduction (%) after application of two algal fucoidan ointments in rats (CTL: control, Pb:
P. boergesenii; Pt: P. tetrastromatica). Each column represents mean ± SD. *P < 0.05 compared to the corresponding
CTL group.

Figure 2. Excisional wound area reduction (%) after application of two algal fucoidan ointments in rats (CTL:
control, Pb: P. boergesenii; Pt: P. tetrastromatica). Each column represents mean ± SD. *P < 0.05 compared to the
corresponding CTL group.

tetrastromatica topical ointment showed significant burn
wound area reduction only on day 7 and had less healing
effect compared to P. boergesenii in the excisional wound
model (Figure 2). As shown in Figures 4 and 6, this
effect was more obvious with P. boergesenii, specifically
in the excisional wound model (P < 0.05) wound area
reduction. With the burn wounds, the scabs started to
come off especially at the boundaries of the wound surface,
manifesting a pink scar underneath (Figure 3).

3.3. Effects on histopathology of the wounds
As shown in Figures 5 and 6, microscopic examinations
of wound samples treated by both algal fucoidans showed
marked changes in healing processes. These changes
included early fibroblast appearances in the wounds’
nearby tissues, especially on day 7; hair follicle and collagen
fiber formations across the wounded skin; increase in
epidermis thickness on day 14; and early inflammatory
cells’ disappearance in the wound area (Figures 5 and 6).
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Figure 3. Photographs of burn wounds treated with two different algal fucoidan ointments on days 3, 7, 10, and 14. A)
Control wounds corresponding to P. tetrastromatica fucoidan ointment, B) wounds treated by P. tetrastromatica, C) control
wounds corresponding to P. boergesenii, D) wounds treated by P. boergesenii. Both algal fucoidan ointments had significant
effects on wound area reduction. Specifically, P. boergesenii showed significant wound healing effects on days 7, 10, and 14.

4. Discussion
The search for new materials with high efficacy of wound
healing among natural resources has been the pillar of
many investigations in recent decades. Marine biological
products, as a potential source of pharmacologically active
agents, have attracted the attention of many researchers
(18).
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In this study, compositional analysis of fucoidans
showed that the extraction/purification processes were
quite efficient in isolating the fucose-containing sulfated
polysaccharide (Table). The yields of fucoidan extraction
and purification for both seaweeds were higher than 1%
(up to 4.5% for P. boergesenii), which were close to other
reported brown seaweed fucoidan content values (1.1%–
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Figure 4. Photographs of excisional wounds treated with two different algal fucoidan ointments on days 3, 7,
10, and 14. A) Control wounds corresponding to P. tetrastromatica fucoidan ointment, B) wounds treated by P.
tetrastromatica, C) control wounds corresponding to P. boergesenii, D) wounds treated by P. boergesenii. Both
algal fucoidan ointments had significant effects on wound area reduction. Specifically, P. boergesenii showed
significant wound healing effects on all days after the treatment (P < 0.05) while P. tetrastromatica showed less
healing effects in this model on days 3, 7, and 14 (P < 0.05).

4.8%) (6,19). On the other hand, the sulfation extents for
both purified fucoidans are relatively higher than those

of previously reported fucoidans, which is a key factor
for their bioactivities. The position of the sulfate group
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Figure 5. Light microscopic examination of rats’ burn wounds after 7 days (A, B, C, D) or 14 days
(E, F, G, H) of treatment with P. boergesenii (B, F), P. tetrastromatica (D, H), or vehicle (A, C, E, G).
A) Control (the ointment base)-treated burn wound after 7 days: necrotic tissues and scab are still
observable on the wound surface with profound neovascularization (BV = blood vessels) and minimal
epidermis and collagen fibers formation. B) P. boergesenii-treated burn wound after 7 days: obvious
epithelium formation with some growing hair follicles (Fol) and fibroblast cells (Fib) observable.
Collagen fibers started to reappear in the deeper tissues. C) Control (the ointment base)-treated burn
wound after 7 days: a thin epithelium layer has been formed with obvious neovascularization (BV =
blood vessels) in underlayer tissue and fibroblast (Fib) cells. Collagen fibers are not formed yet. D)
P. tetrastromatica-treated burn wound after 7 days: a thin epithelium layer has covered the wound
surface. Fibroblast cells (Fib) are observable in the wound underlayer tissue with scanty hair follicles
(Fol) and minimal collagen fiber formation.
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Figure 5. (Continued). E) Control (the ointment base)-treated burn wound after 14 days: epithelium
layer has covered the wound surface along with numerous fibroblast cells (Fib) and some macrophages
(Mac). Collagen fibers and formation of other skin structures are not completed yet. F) P. boergeseniitreated burn wound after 14 days: the wound surface is completely covered by epithelium, and hair
follicles (Fol) and matured collagen (Col) fiber formations are observable. G) Control (the ointment
base)-treated burn wound after 14 days: most of the wound surface is covered by new epithelium (NE)
with some remaining scab on the wound surface and extensive deeper tissue neovascularization (BV
= blood vessels). H) P. tetrastromatica-treated burn wound after 14 days: complete skin formation
with normal epithelium, hair follicles (Fol), and collagen fibers.
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Figure 6. Light microscopic examination of rats’ excisional wounds after 7 days (A, B, C, D) or 14
days (E, F, G, H) of treatment with P. boergesenii (B, F), P. tetrastromatica (D , H), or vehicle (A, C, E,
G). A) Control (the ointment base)-treated excisional wound after 7 days: wound surface still covered
by blood clot and the epithelium layer is not complete. Inflammatory cells and edema (Od) are still
observable in wound underlayer tissue. B) P. boergesenii-treated excisional wound after 7 days: obvious
epithelium formation with some fibroblasts (Fib) along with a few inflammatory cells. C) Control
(the ointment base)-treated excisional wound after 7 days: a thin epithelium layer has been formed
with obvious neovascularization (BV = blood vessel) and some inflammatory cells (i.e. macrophage =
Mac) in the wound area. D) P. tetrastromatica-treated excisional wound after 7 days: epithelium layer
has efficiently covered the wound surface, though some inflammatory cells (i.e. macrophage = Mac),
neovascularization (BV = blood vessels), and collagen fiber formations are still observable.
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Figure 6. (Continued). E) Control (the ointment base)-treated excisional wound after 14 days:
epithelium layer has completely covered the wound surface with numerous fibroblast cells (Fib).
A reduction in the neovascularization (BV = blood vessels) and formation of some collagen fibers
(Col) are observable. F) P. boergesenii-treated excisional wound after 14 days: epithelium layer has
completely covered the wound surface with a reduction in the neovascularization. Some hair follicles
(Fol) and collagen fiber (Col) formations are observable. G) Control (the ointment base)-treated
excisional wound after 14 days: the wound surface is covered by epithelium but some inflammatory
cells along with fibroblasts (Fib) and neovascularization (BV = blood vessels) are observable. H) P.
tetrastromatica-treated excisional wound after 14 days: a typical normal epithelium with keratin layer
along with well-organized collagen fibers (Col) and hair follicles (Fol) are observable.
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is another important issue that determines fucoidan’s
biological properties (20).
Significant wound area reductions, induced by both
algal fucoidans, were observable at some time points (from
day 3 to day 14) (Figures 3 and 4). Microscopic findings
also revealed improvement in wound healing processes
by both algal fucoidans, which included shortening of
the angiogenesis stage, early fibroblast proliferation, and
increased hair follicle and epidermis formation (Figures 5
and 6).
Fucoidans extracted from different algae species
have shown broad ranges of pharmacological activities
including antioxidant, antiviral, anticoagulant, and
immunomodulating properties (6,7,11,20). The members
of the genus Padina are rich in fucoidans, which have
shown several pharmacological activities (21,22). For
example, as a constituent of a moist wound dressing,
fucoidans successfully improved the wound-healing
process by increasing inflammatory cell mobilization in a
rat impaired wound-healing model (4).
Wound area reduction is an important step in the
wound-healing process, especially in excisional wound
models (9). In our study the P. boergesenii extracted
fucoidans showed significant wound area reduction
improvement (better than P. tetrastromatica), especially
in the excisional model (P < 0.05) (Figures 1 and 4). The
exact mechanism behind this contraction is not fully
understood but it seems that a complex interaction between
contractile fibroblasts called myofibroblasts and the matrix
components may be involved (23). An improvement in the
matrix formation and fibroblast migration into the wound
area, following the primary inflammatory phase, might be
helpful in this step. Due to histopathological differences,
contraction changes in excisional wounds are much more
informative than in burn wounds (24) and our data with P.
boergesenii support this fact (Figures 1 and 2). The sulfate
content of P. boergesenii extracted polysaccharides (32.6
± 1%) was quite higher than that of P. tetrastromatica (19
± 1%). The higher sulfate content might be attributed to
better wound-healing properties (25).
The purified fucoidans may be involved in enhancing
paracrine cellular interactions by inducing production
of growth factors or their stabilization, much more like
heparin activity (26,27). Previously, it was shown that
fucoidans bind to some growth factors (e.g., HGF, FGFs)
and stabilize them (28).
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Neovascularization in the wound-healing process
is secondary to secretion of important growth factors
like vascular endothelial growth factor, basic fibroblast
growth factor, and TGF-β (9). Some investigators think
that angiogenesis is the rate-limiting step in the woundhealing process (29). An enhanced phase of proliferation
might lead to faster angiogenesis, and by consequent
improvement in the wound remodeling phase, the
microscopically observed vasculatures disappear sooner
than in a delayed healing process. It has been shown that
basic fibroblast growth factor (FGF-2), a well-known
cytokine with mitogenic properties for fibroblasts and
vascular endothelial cells, could induce angiogenesis
in vivo (20). In concordance with this hypothesis, we
observed that the extent of vascular beds decreased in
histopathologic samples obtained from excisional and
burn wounded animals treated by both algal fucoidans
(Figures 5 and 6).
Improvement in epithelium formation was observable
with both algal fucoidans (Figures 5 and 6). Successful
excisional wound reepithelization depends on a
combination of factors including efficient proliferation
and migration of epidermal progenitor cells from the edge
of injured skin and hair follicles (9). Both algal fucoidans
might have shown their stimulating effects on epithelium
primarily by improving the fibroblast migration into the
wound area and consequent paracrine effects.
We have shown, for the first time, that fucoidans
purified from two brown algae (P. boergesenii and P.
tetrastromatica) from Persian Gulf habitats are rich in
sulfate and have healing properties in full-thickness burn
and excisional wound models in rat. The topical ointment
made of P. boergesenii’s fucoidan seems to be more effective
than that of P. tetrastromatica, especially in excisional
wound healing models, and this might be correlated to its
higher sulfate content.
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